Immunic, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 29.58 million compared to USD 25.27 million a year ago. Basic loss per share from continuing operations was USD 0.3 compared to USD 0.58 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.225 USD | -0.41% | +2.48% | -17.33% |
May. 08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.33% | 111M | |
+17.82% | 125B | |
+14.25% | 108B | |
-7.42% | 23.64B | |
+2.01% | 22.39B | |
-12.44% | 17.78B | |
-41.74% | 16.43B | |
-15.46% | 16.34B | |
+0.45% | 13.56B | |
+25.13% | 11.59B |
- Stock Market
- Equities
- IMUX Stock
- News Immunic, Inc.
- Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024